Home » Stocks » JAZZ

Jazz Pharmaceuticals PLC (JAZZ)

Stock Price: $173.26 USD -0.67 (-0.39%)
Updated Jul 26, 2021 4:00 PM EDT - Market closed
Market Cap 10.56B
Revenue (ttm) 2.44B
Net Income (ttm) 518.28M
Shares Out 60.98M
EPS (ttm) 9.07
PE Ratio 19.09
Forward PE 12.55
Dividend n/a
Dividend Yield n/a
Trading Day July 26
Last Price $173.26
Previous Close $173.93
Change ($) -0.67
Change (%) -0.39%
Day's Open 173.58
Day's Range 173.00 - 175.41
Day's Volume 341,356
52-Week Range 107.59 - 189.00

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Jazz Pharma is not the most popular drugmaker, but it is definitely worth a second look.

2 days ago - The Motley Fool

DUBLIN, July 22, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the National Comprehensive Cancer Network® (NCCN) added Rylaze™ (asparaginase erwinia chrysanthemi (rec...

4 days ago - PRNewsWire

DUBLIN, July 20, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2021 second quarter financial results on Tuesday, August 3, 2021 after the close of ...

6 days ago - PRNewsWire

These 10 stocks to buy have strong free cash flow margins and are trading near the S&P 500's year-to-date return. The post 10 Stocks to Buy That Will Double in the Second Half of 2021 appeared first on ...

Other stocks mentioned: BHP, COLM, DOOR, FTI, G, IX, NOMD ...
1 week ago - InvestorPlace

JAZZ, MRNS, TWO, NCMI, and CRON have been added to the Zacks Rank #5 (Strong Sell) List on July 16, 2021

Other stocks mentioned: CRON, MRNS, NCMI, TWO
1 week ago - Zacks Investment Research

Big Pharmaceutical Companies That Are Top Medicinal Cannabis Stocks The post Best Medical Marijuana Stock To Buy In 2021? 2 With Long Term Potential Right Now appeared first on Marijuana Stocks | Cannab...

Other stocks mentioned: ABBV
1 week ago - MarijuanaStocks

DUBLIN, July 13, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will host a webcast on Tuesday, July 20, 2021 at 4:30 p.m. ET / 9:30 p.m.

1 week ago - PRNewsWire

Pharma stocks like MNMD stock and ANVS stock offer investors long-term growth potential in a market on track to hit a value of $1.70 trillion. The post 7 Top-Rated Pharmaceutical Companies to Invest In ...

Other stocks mentioned: ANVS, BTX, CTXR, MNMD, SAVA, SWTX
2 weeks ago - InvestorPlace

These companies can be serious moneymakers for discount-seeking investors.

Other stocks mentioned: F, FB
2 weeks ago - The Motley Fool

Jazz Pharma (JAZZ) gets FDA approval for Rylaze to treat acute lymphoblastic leukemia or lymphoblastic lymphoma with hypersensitivity to asparaginase.

3 weeks ago - Zacks Investment Research

The FDA has approved Jazz Pharmaceuticals plc (NASDAQ: JAZZ) Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma in ...

3 weeks ago - Benzinga

DUBLIN, June 30, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the U.S. Food and Drug Administration (FDA) approval of Rylaze ™  (asparaginase erwinia chrysanthemi (recomb...

3 weeks ago - PRNewsWire

They are great options whether you are investing for the short or long term.

Other stocks mentioned: SU, WDC
3 weeks ago - The Motley Fool

U.S. Food and Drug Administration published its summary of clinical superiority findings for Xywav for the treatment of cataplexy or excessive daytime sleepiness in patients 7 years of age and older wit...

1 month ago - PRNewsWire

Within the last quarter, Jazz Pharmaceuticals (NASDAQ:JAZZ) has observed the following analyst ratings: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 0 1 1 1 Somewhat Bullish 1 1 0 0 Indiff...

1 month ago - Benzinga

ABT, BNL, ITRG, JAZZ, and MANU have been added to the Zacks Rank #5 (Strong Sell) List on June 22, 2021

Other stocks mentioned: ABT, BNL, ITRG, MANU
1 month ago - Zacks Investment Research

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) has updated its full-year 2021 financial guidance to incorporate the GW Pharmaceuticals business, which the company acquired on May 5. Forecasts total net product...

1 month ago - Benzinga

DUBLIN, June 17, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today updated its full year 2021 financial guidance to incorporate the GW Pharmaceuticals (GW) business, which the Company a...

1 month ago - PRNewsWire

2 Marijuana Stocks To Add To Your Watchlist In June The post 2 Marijuana Stock To Add To Your Watchlist This Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding I...

Other stocks mentioned: FFNTF
1 month ago - MarijuanaStocks

According to the GuruFocus discounted cash flow calculator as of June 16, the following companies have a high margin of safety and have grown their margins over a 10-year period.

Other stocks mentioned: ATHM, SEIC, TTC, UHAL
1 month ago - GuruFocus

If screening the market for value opportunities, investors may want to consider the following stocks, since their prices are trading at a discount to the intrinsic value calculated by GuruFocus' earning...

Other stocks mentioned: ACGL, MKL
1 month ago - GuruFocus

According to the GuruFocus All-in-One Screener, a Premium feature, the following guru-owned defensive companies have grown their book value per share over the past decade through June 14.

Other stocks mentioned: ANTM, COO, EBS, HUM
1 month ago - GuruFocus

DUBLIN, June 14, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the launch of Nothing Small About It (www.nothingsmallaboutit.com), an online program developed with consult...

1 month ago - PRNewsWire

DUBLIN, June 9, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that 13 abstracts sponsored by Jazz Pharmaceuticals and five abstracts from investigator-sponsored trials wil...

1 month ago - PRNewsWire

NEW YORK, June 4, 2021 /PRNewswire/ -- Notice is hereby given that Monteverde & Associates PC has filed a class action lawsuit in the United States District Court for the Southern District of California...

Other stocks mentioned: GWPH
1 month ago - PRNewsWire

Jazz (JAZZ) reported earnings 30 days ago. What's next for the stock?

1 month ago - Zacks Investment Research

2 Biotech Cannabis Stocks To Watch Next Month As marijuana stocks continue… The post 2 Biotech Cannabis Stocks To Watch In June 2021 appeared first on Marijuana Stocks | Cannabis Investments and News. R...

Other stocks mentioned: ABBV
1 month ago - MarijuanaStocks

DUBLIN, May 26, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that its senior management team will provide a company overview and business and financial updates at the Jef...

2 months ago - PRNewsWire

These Could Be Cannabis Investments For Your Long Term Portfolio The post The Best Long Term Cannabis Stocks Right Now? 2 For To Watch In May appeared first on Marijuana Stocks | Cannabis Investments an...

Other stocks mentioned: MSOS
2 months ago - MarijuanaStocks

DUBLIN, May 20, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it and its investigator sponsors will present four new abstracts at the virtual American Society of Clin...

2 months ago - PRNewsWire

And ignoring it could cost you significant returns.

Other stocks mentioned: ACB, CURLF, GRWG, SNDL, TCNNF
2 months ago - The Motley Fool

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will conti...

Other stocks mentioned: ARNA, GWPH, HEXO, HUGE, IIPR, OGI, TLRY ...
2 months ago - Schaeffers Research

The biopharmaceutical company Jazz Pharmaceuticals (NASDAQ: JAZZ), has finalized the acquisition of the cannabinoid drug company GW Pharmaceuticals plc. (NASDAQ: GWPH).

Other stocks mentioned: GWPH
2 months ago - Benzinga

Jazz (JAZZ) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

2 months ago - Zacks Investment Research

The developer of cannabis-based medications is now under new ownership.

Other stocks mentioned: GWPH
2 months ago - The Motley Fool

Jazz Pharmaceuticals (JAZZ) reports mixed first-quarter 2021 results as earnings beat estimates while sales miss the same. Shares down

2 months ago - Zacks Investment Research

DUBLIN, May 5, 2021 /PRNewswire/ -- Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced the completion of its acquisition of GW Pharmaceuticals plc (Nasdaq: GWPH) ("GW"), a leader in the science, develo...

Other stocks mentioned: GWPH
2 months ago - PRNewsWire

Jazz (JAZZ) delivered earnings and revenue surprises of 6.23% and 0.16%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

DUBLIN, May 4, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that its senior management team will provide a company overview and business and financial updates at the foll...

2 months ago - PRNewsWire

DUBLIN, May 4, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the first quarter of 2021 and affirmed financial guidance for 2021. "Demand for Xywav is...

2 months ago - PRNewsWire

DUBLIN, April 29, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (the "Company" or "Jazz") today announced the closing of its previously announced offering (the "Offering") of $1.5 billion...

2 months ago - PRNewsWire

Jazz is about to get the top cannabis-derived drug on the market, in addition to a robust pipeline.

Other stocks mentioned: GWPH
3 months ago - The Motley Fool

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will conti...

Other stocks mentioned: APHA, ARNA, CGC, CRBP, GWPH, IIPR, NEPT ...
3 months ago - Schaeffers Research

Are These Top Cannabis Stocks To Invest In Right Now? The post Looking For Marijuana Stocks To Buy On Robinhood? 2 For Your Watchlist Next Week appeared first on Marijuana Stocks | Cannabis Investments ...

Other stocks mentioned: ABBV, APHA, GWPH, PFE, TLRY
3 months ago - MarijuanaStocks

DUBLIN, April 22, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (the "Company" or "Jazz") today announced the pricing of the previously announced offering (the "Offering") of $1.5 billion...

3 months ago - PRNewsWire

JAZZ vs. ZTS: Which Stock Is the Better Value Option?

Other stocks mentioned: ZTS
3 months ago - Zacks Investment Research

While Biogen rides a big-cap rollercoaster, a few small players are creating better trading opps.

Other stocks mentioned: AVXL, AXSM, BIIB, SAVA
3 months ago - Zacks Investment Research

P/B ratio is emerging as a convenient tool for identifying low-priced stocks that have high growth prospects

Other stocks mentioned: ASX, ATCO, GS, MT, OMI
3 months ago - Zacks Investment Research

DUBLIN, April 20, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (the "Company") announced today that its wholly owned subsidiary, Jazz Securities Designated Activity Company (the "Issuer"...

3 months ago - PRNewsWire

DUBLIN, April 20, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced positive results from the Phase 3 study of XywavTM (calcium, magnesium, potassium, and sodium oxybates) ora...

3 months ago - PRNewsWire

About JAZZ

Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement disorders; and in oncology, including hematologic and solid tumors. Its lead marketed products include Xyrem, an oral solution for the treatment of cataplexy and excessive daytime sleepiness (EDS) in narc... [Read more...]

Industry
Biotechnology
IPO Date
Jun 1, 2007
Stock Exchange
NASDAQ
Ticker Symbol
JAZZ
Full Company Profile

Financial Performance

In 2020, JAZZ's revenue was $2.36 billion, an increase of 9.34% compared to the previous year's $2.16 billion. Earnings were $238.62 million, a decrease of -54.41%.

Financial Statements

Analyst Forecasts

According to 20 analysts, the average rating for JAZZ stock is "Buy." The 12-month stock price forecast is 207.12, which is an increase of 19.54% from the latest price.

Price Target
$207.12
(19.54% upside)
Analyst Consensus: Buy